Abstract
Malaria is one of the most dangerous diseases in developing countries. The chemotherapy of malaria has been based on drugs developed more than half a century ago. These drugs are continuously losing their efficacy, mainly due to multi-drug resistance developed by the malaria-causing parasite. In the last three decades, artemisinin and artemisinin-like compounds have proven to be efficient alternatives to the chemotherapeutic control of malaria. These facts have led to an increasing interest in the development of Quantitative Structure Activity Relantioship (QSAR) models for these compounds. This work presents a critical view on some QSAR models, and shows that, due to lack of a rigorous selection of the descriptors entering the models, most of them are unable to accurately indicate the molecular cause of biological activity. Some reasons for the weakness of the published models are discussed.
Keywords: QSAR, malaria, artemisinin, endoperoxide, mechanism of action, mefloquine, chloroquine, Plasmodium falciparum, artemisinin, Plasmodium sp, lipophilic, glutathione-S-transferase, sulfotransferases
Mini-Reviews in Medicinal Chemistry
Title:A Critical View on Antimalarial Endoperoxide QSAR Studies
Volume: 12 Issue: 6
Author(s): R. R. Teixeira, J. W. de M. Carneiro, M. T. de Araujo and A. G. Taranto
Affiliation:
Keywords: QSAR, malaria, artemisinin, endoperoxide, mechanism of action, mefloquine, chloroquine, Plasmodium falciparum, artemisinin, Plasmodium sp, lipophilic, glutathione-S-transferase, sulfotransferases
Abstract: Malaria is one of the most dangerous diseases in developing countries. The chemotherapy of malaria has been based on drugs developed more than half a century ago. These drugs are continuously losing their efficacy, mainly due to multi-drug resistance developed by the malaria-causing parasite. In the last three decades, artemisinin and artemisinin-like compounds have proven to be efficient alternatives to the chemotherapeutic control of malaria. These facts have led to an increasing interest in the development of Quantitative Structure Activity Relantioship (QSAR) models for these compounds. This work presents a critical view on some QSAR models, and shows that, due to lack of a rigorous selection of the descriptors entering the models, most of them are unable to accurately indicate the molecular cause of biological activity. Some reasons for the weakness of the published models are discussed.
Export Options
About this article
Cite this article as:
R. Teixeira R., W. de M. Carneiro J., T. de Araujo M. and G. Taranto A., A Critical View on Antimalarial Endoperoxide QSAR Studies, Mini-Reviews in Medicinal Chemistry 2012; 12 (6) . https://dx.doi.org/10.2174/138955712800493852
DOI https://dx.doi.org/10.2174/138955712800493852 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
BCR-ABL Inhibitors in Chronic Myeloid Leukemia: Process Chemistry and Biochemical Profile
Current Medicinal Chemistry Advanced Methods for the Analysis of Testosterone
Current Medicinal Chemistry Pharmacological Exploitation of Indole-3-Carbinol to Develop Potent Antitumor Agents
Mini-Reviews in Medicinal Chemistry NADPH Oxidases and Inflammatory Bowel Disease
Current Medicinal Chemistry Recent Development and SAR Analysis of Colchicine Binding Site Inhibitors
Mini-Reviews in Medicinal Chemistry Osteoprotegerin A Physiological and Pharmacological Inhibitor of Bone Resorption.
Current Pharmaceutical Design The Role of Adenosine in Bone: An Emerging Concept
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Clinical Development of MET Targeted Therapy For Human Cancer
Current Cancer Therapy Reviews Targeting Nanoparticles as Drug Delivery Systems for Cancer Treatment
Current Nanoscience MIF and CD74 - Suitability as Clinical Biomarkers
Mini-Reviews in Medicinal Chemistry In Vivo Anticancer Activity, Toxicology and Histopathological Studies of the Thiolate Gold(I) Complex [Au(Spyrimidine)(PTA-CH<sub>2</sub>Ph)]Br
Anti-Cancer Agents in Medicinal Chemistry Peptide Nucleic Acids: A Novel Approach
Current Chemical Biology Safety of Cabergoline in the Management of Pituitary Prolactin-Induced Symptoms with Patients Treated with Atypical Neuroleptics
Current Drug Safety Novel Antitumor Strategies Using Cytokine PEDF for Prostate Cancer Therapy
Current Angiogenesis (Discontinued) Preface [Hot topic:Testicular and Prostatic Pathologies (Executive Editor : Eric Reiter)]
Current Pharmaceutical Design Influence of Biological and Technical Covariates on Non-targeted Metabolite Profiling in a Large-scale Epidemiological Study
Current Metabolomics New Molecular Targets of Anticancer Therapy – Current Status and Perspectives
Current Medicinal Chemistry Tissue Elastography: Advances in Imaging the Mechanical Properties of Tissue
Recent Patents on Electrical Engineering PET Radiochemistry Automation: State of the Art and Future Trends in 18F-nucleophilic Fluorination
Current Organic Chemistry Ultrasensitive Electrochemical Sensors for PSA Detection: Related Surface Functionalization Strategies
Current Topics in Medicinal Chemistry